Skip to main content
Clinical Trials/NCT05580848
NCT05580848
Not yet recruiting
Not Applicable

Wrist Arthroscopy During Surgical Treatment of Distal Radius Fractures Improves Functional Outcome: a Randomized Controlled Trial

Clinic for Orthopedics Lovran0 sites56 target enrollmentNovember 20, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fracture
Sponsor
Clinic for Orthopedics Lovran
Enrollment
56
Primary Endpoint
DASH Score
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

Wrist arthroscopy (WA) is a potentially useful adjuvant procedure in the surgical treatment (osteosynthesis) of distal radius fractures (DRFs). Previous research on the contribution of WA to DRF treatment has shown different results.

Objectives of the study: (1) Validate wrist functional outcome questionnaires; (2) To determine whether arthroscopically assisted repositioning of fracture fragments in articular DRFs leads to a better treatment outcome; (3) To determine whether arthroscopic observation and treatment of associated soft tissue and / or cartilage injuries in articular DRFs leads to a better treatment outcome; (4) To determine whether arthroscopic observation and treatment of associated soft tissue and / or cartilage injuries in extraarticular DRFs leads to a better treatment outcome.

Research hypotheses: (1) Validated questionnaires will have satisfactory measurement properties (validity, reliability) and will be able to be used in a WA randomized controlled trial; (2) WA as an adjunct to DRF osteosynthesis improves the clinical outcome of treatment.

Subjects: 56 female patients with indication for DRF osteosynthesis aged 50-69 years divided into 2 groups: 1. examined - 28 patients with indication for DRF osteosynthesis (14 patients with extraarticular DRF and 14 patients with intraarticular DRF) with associated WA, and 2. control - 28 patients with indication for DRF osteosynthesis (14 patients with extraarticular DRF and 14 patients with intraarticular DRF) without associated WA.

Methods: As a primary outcome measure, functional outcomes of treatment will be analyzed with the Disabilities of the Arm, Shoulder and Hand (DASH) Score at 3 and 6 months after surgery. As a secondary outcome measures it will be analyzed pain level according to a visual analog scale (VAS), preoperative and postoperative radiographic parameters of distal radius, and clinical outcomes of treatment with the Mayo Wrist Score (MWS) and Patient-Rated Wrist Evaluation (PRWE) score at 3 and 6 months after surgery. Expected scientific contribution: providing answers on the role of WA in the treatment of DRF and associated injuries as well as its impact on treatment outcome.

Registry
clinicaltrials.gov
Start Date
November 20, 2022
End Date
September 20, 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Clinic for Orthopedics Lovran
Responsible Party
Principal Investigator
Principal Investigator

Borjan Josifovski

Principal Investigator

Clinic for Orthopedics Lovran

Eligibility Criteria

Inclusion Criteria

  • Distal radius fractures with an indication for surgical treatment according to the AO/OTA classification of patients aged 50-69 years who have signed an informed consent to participate in the research.

Exclusion Criteria

  • Distal radius fractures( DRF) that have an indication for surgical treatment in all patients and in patients younger than 50 and older than 69,
  • DRF that do not have an indication for surgical treatment,
  • Refusal to participate in the research,
  • Inability to decide independently about participation in the research (persons under guardianship),
  • Open fractures,
  • Presence of severe soft tissue injuries,
  • Infections,
  • Poor general condition of patients and internal medicine contraindications.

Outcomes

Primary Outcomes

DASH Score

Time Frame: 6 months after surgery

Disabilities of the Arm, Shoulder and Hand It consists of 30 questions and is used to assess functional disorders of the upper extremity. 21 questions examine the extent to which the patient had problems performing certain activities during the last week. 6 questions assess specific symptoms (eg, pain, paresthesias, sleep disturbances) during the last week, and 3 questions assess social or occupational limitations during the last week. The possible score ranges from 0 to 100 points. 0 points represents complete, unrestricted function of the upper extremities, while 100 points represents the greatest possible functional impairment.

Secondary Outcomes

  • VAS(6 months after surgery.)
  • MWS(6 months after surgery.)
  • PRWE(6 months after surgery.)

Similar Trials